SCHEMBL8796152

SCHEMBL8796152

CCOC(=O)C(CC)(c1cccc(F)c1)P(=O)(O)OCC

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.41
KCNN4 O15554 4/20 0.38
LMNA P02545 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
HTT P42858 2/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
GLA P06280 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796508 0.88 NPSR1 (0.42) POLBLMNASMN1; SMN2MAPTMEN1
SCHEMBL8796091 0.85 ALDH1A1 (0.40) POLBLMNASMN1; SMN2MAPTMEN1
SCHEMBL8795835 0.85 KMT2A (0.39) KCNN4LMNASMN1; SMN2TDP1MAPT
SCHEMBL8796326 0.84 SMN1; SMN2 (0.46) POLBKCNN4SMN1; SMN2MAPTMEN1
SCHEMBL17420423 0.74 POLB (0.51) POLBKCNN4LMNASMN1; SMN2TDP1
SCHEMBL1508218 0.74 KCNN4 (0.47) KCNN4LMNAMEN1GAAKMT2A
SCHEMBL5004403 0.73 POLB (0.47) POLBKCNN4LMNASMN1; SMN2TDP1
SCHEMBL11578597 0.72 SMN1; SMN2 (0.49) POLBSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL19797979 0.71 KCNN4 (0.46) POLBKCNN4LMNASMN1; SMN2TDP1
SCHEMBL29145552 0.70 POLB (0.47) POLBKCNN4LMNASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed